Related Experiment Videos
Beclomethasone nasal spray in the treatment of middle-ear effusion - a double-blind study
Insights
Beclomethasone dipropionate nasal spray did not significantly impact middle ear effusion in children aged 4-14. This study found no therapeutic benefit for this condition using the tested nasal spray treatment.
Area of Science:
- Otolaryngology
- Pediatric Medicine
- Pharmacology
Background:
- Middle ear effusion (MEE) is a common condition in children, often leading to hearing difficulties.
- Nasal corticosteroids are sometimes considered for MEE, but evidence of efficacy is limited.
- Beclomethasone dipropionate is a widely used intranasal corticosteroid.
Purpose of the Study:
- To evaluate the efficacy of beclomethasone dipropionate nasal spray in treating middle ear effusion in children.
- To compare the outcomes of beclomethasone dipropionate versus placebo in pediatric patients with MEE.
Main Methods:
- A double-blind, placebo-controlled study was conducted.
- Seventy children (aged 4-14 years) received either beclomethasone dipropionate (400 micrograms/day) or a placebo nasal spray for one month.
- Outcomes were assessed using tympanometry, audiometry, and otomicroscopy.
Main Results:
- Statistical analysis showed no significant difference between the beclomethasone dipropionate group and the placebo group.
- P-values were approximately 0.5, indicating a lack of statistically significant effect.
- Objective measures of middle ear effusion did not improve with the active drug compared to placebo.
Conclusions:
- Beclomethasone dipropionate nasal spray demonstrated no significant effect on middle ear effusion in the studied pediatric population.
- The findings suggest that this intranasal corticosteroid is not an effective treatment for middle ear effusion in children.
- Further research may be needed to explore other therapeutic avenues for MEE.
Abstract:
The effect of a beclomethasone dipropionate nasal spray on middle ear effusion was tested in a double-blind study of drug vs placebo (vehicle). Seventy children, aged 4-14 years, sprayed each nostril twice daily for one month. Among them 35 received a daily dose of 400 micrograms of the beclomethasone. The results of tympanometry, audiometry and otomicroscopy were compared in the two groups, and the statistical analysis revealed P-values around 0.5. The conclusion is that the active drug had no effect on middle ear effusion in the population investigated.